<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04771065</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL21_0106</org_study_id>
    <nct_id>NCT04771065</nct_id>
  </id_info>
  <brief_title>Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Intractable Epilepsy</brief_title>
  <official_title>Microendoscopic Transventricular Deep Brain Stimulation of the Anterior Nucleus of the Thalamus as a Safe and Efficient Treatment in Intractable Epilepsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Deep Brain Stimulation (DBS) of the anterior nucleus of the thalamus (ANT) has been proposed&#xD;
      in patients with severe intractable epilepsy. When used, the transventricular approach&#xD;
      increases the risk of bleeding due the anatomy around the entry point in the thalamus. To&#xD;
      avoid such a complication, the investigators used a transventricular microendoscopic&#xD;
      technique.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 29, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Absence of hemorraghic complication</measure>
    <time_frame>1 day</time_frame>
    <description>Absence of hemorraghic complication on post operative MRI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>responder rate</measure>
    <time_frame>1 year</time_frame>
    <description>50%-responder rate (on seizures)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>responder rate</measure>
    <time_frame>2 years</time_frame>
    <description>50%-responder rate (on seizures)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>responder rate</measure>
    <time_frame>5 years</time_frame>
    <description>50%-responder rate (on seizures)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Refractory Epilepsy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        adult patients extracted from our prospective database, who have been surgically treated&#xD;
        between 2010 and 2019 for refractory epilepsy by deep brain stimulation (DBS) of the&#xD;
        anterior thalamic nucleus using microendoscopy. All patients had a minimum follow up of 1&#xD;
        year. Refractory epilepsy was defined as failure of at least 3 anti-epileptic drugs (AEDs)&#xD;
        to produce adequate seizure control&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  adult patients&#xD;
&#xD;
          -  treated between 2010 and 2019 for refractory epilepsy by DBS of the anterior nucleus&#xD;
             os the thalamus using microendoscopy&#xD;
&#xD;
          -  minimum follow-up of 1-year&#xD;
&#xD;
          -  refractory epilepsy defined as failure of at least 3 antiepileptic drugs&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
        - age &lt; 18 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gaëtan Poulen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gaëtan Poulen, MD</last_name>
    <phone>467337262</phone>
    <phone_ext>33</phone_ext>
    <email>g-poulen@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaëtan Poulen, MD</last_name>
      <phone>467337262</phone>
      <phone_ext>33</phone_ext>
      <email>g-poulen@chu-montpellier.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 22, 2021</study_first_submitted>
  <study_first_submitted_qc>February 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 25, 2021</study_first_posted>
  <last_update_submitted>February 22, 2021</last_update_submitted>
  <last_update_submitted_qc>February 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>epilepsy</keyword>
  <keyword>deep brain stimulation</keyword>
  <keyword>thalamus</keyword>
  <keyword>endoscopy</keyword>
  <keyword>stereotaxy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Drug Resistant Epilepsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

